Patents by Inventor Richard L. Beard

Richard L. Beard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Insulated container with bottle opener
    Patent number: 8245600
    Abstract: An insulated container for holding a beverage container, such as a bottle or a can, is disclosed. An insulation liner is provided in the container. The insulated container incorporates a bottle opener into the sidewall of the container. The bottle opener has a lip and a leverage surface. A magnet is provided on the leverage surface, to hold the cap after it has been removed from the bottle.
    Type: Grant
    Filed: September 1, 2009
    Date of Patent: August 21, 2012
    Inventor: Richard L. Beard
  • Novel 1-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)Urea Derivatives As N-FORMYL Peptide Receptor Like-1 (FPRL-1) Receptor Modulators
    Publication number: 20120208842
    Abstract: The present invention relates to novel 1-(1-Oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) receptor.
    Type: Application
    Filed: February 10, 2012
    Publication date: August 16, 2012
    Applicant: ALLERGAN, INC
    Inventors: Richard L. Beard, John E. Donello, Tien T. Duong, Michael E. Garst, Veena Viswanath
  • NOVEL 1,2- BIS-SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS
    Publication number: 20120157444
    Abstract: The present invention relates to novel bis-sulfonamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.
    Type: Application
    Filed: December 12, 2011
    Publication date: June 21, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Haiqing Yuan, Richard L. Beard, Xiaoxia Liu, John E. Donello, Veena Viswanath, Michael E. Garst
  • PHARMACEUTICAL COMPOSITIONS COMPRISING 3,4-DIHYDROISOQUINOLIN-2(1H)-YL-3-PHENYLUREA DERIVATIVES HAVING FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) AGONIST OR ANTAGONIST ACTIVITY
    Publication number: 20120142726
    Abstract: The present invention relates to a method of treating a disorder associated with modulation of the FPRL-1 receptor which comprises administering a therapeutically effective amount of a pharmaceutical composition comprising a 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivative.
    Type: Application
    Filed: November 21, 2011
    Publication date: June 7, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Richard L. Beard, John E. Donello, Michael E. Garst, Veena Viswanath
  • Bicyclic compounds having activity at the CXCR4 receptor
    Patent number: 8193203
    Abstract: A compound represented by the structural formula: Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: May 18, 2009
    Date of Patent: June 5, 2012
    Assignee: Allergan, Inc.
    Inventors: Richard L. Beard, Tien T. Duong, Thong H. Vu, Vidyasagar Vuligonda, John E. Donello, Michael E. Garst, Gerard A. Rodrigues
  • Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
    Patent number: 8188279
    Abstract: Disclosed herein are compounds represented by the structural formula: therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: June 1, 2011
    Date of Patent: May 29, 2012
    Assignee: Allergan, Inc.
    Inventors: Santosh C. Sinha, Smita Bhat, Ken Chow, Richard L. Beard, John E. Donello, Michael Garst
  • Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
    Patent number: 8143291
    Abstract: The invention provides well-defined aryl and/or heteroaryl substituted indoles that are useful as sphingosine-1-phosphate agonists or antagonists. As such, the compounds described herein are useful in treating a wide variety of disorders associated with modulation of sphingosine-1-phosphate receptors.
    Type: Grant
    Filed: January 3, 2011
    Date of Patent: March 27, 2012
    Assignee: Allergan, Inc.
    Inventors: Richard L. Beard, Haiqing Yuan, John E. Donello
  • S1P3 Receptor Inhibitors for Treating Conditions of the Eye
    Publication number: 20120071448
    Abstract: Disclosed herein are compositions and methods for treating conditions of the eye using S1P3 receptor inhibitors.
    Type: Application
    Filed: May 4, 2010
    Publication date: March 22, 2012
    Applicant: Allergan, Inc.
    Inventors: John E. Donello, Richard L. Beard, Mohammed I. Dibas
  • Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist
    Patent number: 8097644
    Abstract: The present invention provides novel compounds having the following general formula I wherein: A, B, X, Y, R1, R2, R3, R4, n, o and p are as defined in the specification. Such compounds are useful for treating a disease or condition selected from the group consisting of glaucoma, dry eye, angiogenesis, cardiovascular conditions or diseases and wound healing.
    Type: Grant
    Filed: March 23, 2007
    Date of Patent: January 17, 2012
    Assignee: Allergan, Inc.
    Inventors: Richard L. Beard, John E. Donello, Haiqing Yuan, Vidyasagar Vuligonda, Tien T. Duong
  • DERIVATIVES OF CYCLOALKYL- AND CYCLOALKENYL-1,2-DICARBOXYLIC ACID COMPOUNDS HAVING FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) AGONIST OR ANTAGONIST ACTIVITY
    Publication number: 20110319454
    Abstract: The invention provides well defined compounds having FPRL-1 agonist or antagonist activity. As such, the compounds of the invention are useful for treating a variety of ocular disorders.
    Type: Application
    Filed: June 24, 2011
    Publication date: December 29, 2011
    Applicant: ALLERGAN, INC.
    Inventors: Richard L. Beard, John E. Donello, Vidyasagar Voligonda, Michael E. Garst
  • INDOLE COMPOUNDS BEARING ARYL OR HETEROARYL GROUPS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR BIOLOGICAL ACTIVITY
    Publication number: 20110275677
    Abstract: The invention provides well-defined aryl and/or heteroaryl substituted indoles that are useful as sphingosine-1-phosphate agonists or antagonists. As such, the compounds described herein are useful in treating a wide variety of disorders associated with modulation of sphingosine-1-phosphate receptors.
    Type: Application
    Filed: January 3, 2011
    Publication date: November 10, 2011
    Applicant: ALLERGAN, INC.
    Inventors: Richard L. Beard, Haiqing Yuan, John E. Donello
  • THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS
    Publication number: 20110237797
    Abstract: Disclosed herein are compounds represented by the structural formula: therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: June 1, 2011
    Publication date: September 29, 2011
    Applicant: ALLERGAN, INC.
    Inventors: Santosh C. Sinha, Smita Bhat, Ken Chow, Richard L. Beard, John E. Donello, Michael Garst
  • Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity
    Publication number: 20110105567
    Abstract: Disclosed herein are compounds represented by: therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: August 21, 2008
    Publication date: May 5, 2011
    Applicant: Allergan, Inc.
    Inventors: Richard L. Beard, Hiaqing Yuan, John E. Donello, Ken Chow, Liming Wang
  • INSULATED CONTAINER WITH BOTTLE OPENER
    Publication number: 20110048061
    Abstract: An insulated container for holding a beverage container, such as a bottle or a can, is disclosed. An insulation liner is provided in the container. The insulated container incorporates a bottle opener into the sidewall of the container. The bottle opener has a lip and a leverage surface. A magnet is provided on the leverage surface, to hold the cap after it has been removed from the bottle.
    Type: Application
    Filed: September 1, 2009
    Publication date: March 3, 2011
    Inventor: Richard L. Beard
  • THERAPEUTIC QUINOLINE AND NAPHTHALENE DERIVATIVES
    Publication number: 20110046177
    Abstract: Disclosed herein is a stable compound having a structure formula (I): therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: August 21, 2008
    Publication date: February 24, 2011
    Applicant: ALLERGAN, INC.
    Inventors: Richard L. Beard, Hiaqing Yuan, John E. Donello, Michael E. Garst
  • Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity
    Patent number: 7888336
    Abstract: The invention provides well-defined aryl and/or heteroaryl substituted indoles that are useful as spingosine-1-phosphate agonists or antagonists. As such, the compounds described herein are useful in treating a wide variety of disorders associated with modulation of sphingosine-1-phosphate receptors.
    Type: Grant
    Filed: September 18, 2008
    Date of Patent: February 15, 2011
    Assignee: Allergan, Inc.
    Inventors: Richard L. Beard, Haiqing Yuan, John E. Donello
  • Tetrahydroindoles Having Sphingosine-1-Phosphate Receptor Activity
    Publication number: 20110003876
    Abstract: Compounds are disclosed herein having the formula (I). Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: December 17, 2008
    Publication date: January 6, 2011
    Inventors: Haiqing Yuan, Richard L. Beard
  • S1P3 RECEPTOR INHIBITORS FOR TREATING PAIN
    Publication number: 20100249069
    Abstract: Disclosed herein are compositions and methods for treating pain using S1P3 receptor inhibitors.
    Type: Application
    Filed: May 7, 2008
    Publication date: September 30, 2010
    Inventors: John E. Donello, Richard L. Beard, Fabien J. Schweighoffer
  • Indole Compounds Bearing Aryl or Heteroaryl Groups Having Sphingosine 1-Phosphate (S1P) Receptor Biological Activity
    Publication number: 20100240614
    Abstract: The invention provides well-defined aryl and/or heteroaryl substituted indoles that are useful as spingosine-1-phosphate agonists or antagonists. As such, the compounds described herein are useful in treating a wide variety of disorders associated with modulation of sphingosine-1-phosphate receptors.
    Type: Application
    Filed: September 18, 2008
    Publication date: September 23, 2010
    Inventors: Richard L. Beard, Haiqing Yuan, John E. Donello
  • Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
    Patent number: 7737173
    Abstract: The invention provides compounds represented by the formula I, each of which compounds may have sphingosine-1-phosphate receptor agonist and or antagonist biological activity: and wherein the variables Y, R4, n, A, X, Z, R1, o, R3, R2 and p are as defined in the specification. These compounds are useful for treating a disease or condition selected from the group consisting of glaucoma, dry eye, angiogenesis, cardiovascular conditions and diseases, and wound healing.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: June 15, 2010
    Assignee: Allergan, Inc.
    Inventors: Richard L. Beard, John E. Donello, Haiqing Yuan, Diana F. Colon, Tien Duong, Xiaoxia Liu, Yihui Hu